http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114085140-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e152341910cca8e4886617f6abed32d6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K3-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-412 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-418 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K3-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-41 |
| filingDate | 2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73248414440746582c5891d59cb2abeb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c23329641eec39fa00fc3873312776e3 |
| publicationDate | 2022-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114085140-A |
| titleOfInvention | A kind of technological process for the production of 3,5-di-tert-butyl zinc salicylate |
| abstract | The invention discloses a production process for 3,5-di-tert-butyl zinc salicylate, including four steps of material preparation, reaction preparation, washing and purification, and weighing and packaging, wherein the reaction preparation includes substitution reaction, complexation There are three steps of reaction and mother liquor separation, washing and purification includes three steps of crude product washing, centrifugal refining and solid drying, and finished product packaging includes two steps of crushing into powder and weighing and packaging. The process of metal complex-(3,5-di-tert-butylsalicylic acid) synthesized through the preparation steps is simple to implement, flexible to operate, the yields are all over 90%, and the charge quantity and charge stability are excellent, which can be used for making Antistatic agent and charge control agent for toner, provide high-quality raw materials and intermediates for medicine, antistatic agent and charge control agent for toner, and solve the problems of high cost, cumbersome process and crystal form in the existing manufacturing process. The problem is that the degree of crystallinity is not controlled in place. |
| priorityDate | 2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.